To Evaluate Effect of Food of DA-5222 in Healthy Adult Subjects
ConditionHealthy
Trial statusNot yet recruiting
Trial phasePhase 1
Trial typeInterventional
Biological sexAll
Age19+
SponsorDong-A ST Co., Ltd.
About this trial
This study is to evaluate the effect of food on pharmacokinetics of DA-5222 in healthy adult subjects
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Healthy volunteers
BMI between 18 and 30 kg/m2
Body weight: Male≥50kg, Female≥45kg
Subjects who have signed an informed consent themselves after receiving detailed explanation about clinical study
Disqualifiers
Subjects with clinically significant medical history
Subjects with history of drug abuse or addicted
Subjects with allergy or drug hypersensitivity
Trial design
Design model
Crossover
Treatments tested in this trial
DA-5222
Drugsingle dose administration (DA-5222 one tablet once a day)
Treatment groups
32 Participants
are divided into 2 treatment groupsGroup A: Sequence AExperimental treatment 1 intervention
Group B: Sequence BExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
AUCt
area under the curve
Time frame
pre-dose~72 hours post-dose2
Cmax
maximum plasma concentration
Time frame
pre-dose~72 hours post-doseSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: